WallStreetZenWallStreetZen

NASDAQ: OGI
Organigram Holdings Inc Earnings & Revenue

OGI earnings and revenue history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

OGI Return on Equity

Current Company
N/A
Current Industry
15.5%
Current Market
188%

Be the first to know when OGI announces earnings.

OGI Return on Assets

Current Company
N/A
Current Industry
3.4%

OGI Return on Capital Employed

Current Company
0%
Current Industry
5.1%

OGI vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
OGIN/AN/AN/AN/AN/A
OPTN$70.99M-$15.55M-$35.48M+58.64%N/A
LFCR$103.27M-$68.32M-$99.56M-27.74%N/A
ALIM$80.75M-$1.12M-$21.39M+11.62%N/A
ZOM$24.01M-$16.47M-$14.50M+2,028.25%N/A

OGI earnings dates

Next earnings date
Apr 9, 2024

Organigram Holdings Earnings & Revenue FAQ

What were OGI's earnings last quarter?

On Invalid Date, Organigram Holdings (NASDAQ: OGI) reported Q4 2023 earnings per share (EPS) of -$0.15, up 386.27% year over year. Total Organigram Holdings earnings for the quarter were -$11.88 million. In the same quarter last year, Organigram Holdings's earnings per share (EPS) was $0.05.

If you're new to stock investing, here's how to buy Organigram Holdings stock.

What was OGI's earnings growth in the past year?

As of Q1 2024, Organigram Holdings's earnings has grown year over year. Organigram Holdings's earnings in the past year totalled N/A.

What is OGI's earnings date?

Organigram Holdings's earnings date is Invalid Date. Add OGI to your watchlist to be reminded of OGI's next earnings announcement.

What was OGI's revenue last quarter?

On Invalid Date, Organigram Holdings (NASDAQ: OGI) reported Q4 2023 revenue of $27.41 million up 15.85% year over year. In the same quarter last year, Organigram Holdings's revenue was $32.57 million.

What was OGI's revenue growth in the past year?

As of Q1 2024, Organigram Holdings's revenue has grown null year over year. Organigram Holdings's revenue in the past year totalled N/A.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.